Class action lawsuits - Strategic Insights Report (Page 18)

Class action lawsuits

Lawsuit Filed Against CTO Realty Growth, Inc. - Investors Affected by Misleading Financial Statements

CTO Realty Growth, Inc., a real estate investment trust headquartered in Winter Park, Florida, is being investigated for potential securities law violations. The investigation centers around allegations that the company knowingly misrepresented its financial condition by manipulating key metrics and overstating the profitability of certain properties. A report by short-seller

Class action lawsuits

Neogen Corporation Class Action Lawsuit: Important September 16, 2025 Lead Plaintiff Deadline

The Rosen Law Firm reminds investors who purchased common stock of Neogen Corporation (NASDAQ: NEOG) between January 5, 2023, and June 3, 2025, of the important September 16, 2025, lead plaintiff deadline in the ongoing class action lawsuit. The lawsuit claims that defendants made false and/or misleading statements about

Class action lawsuits

KinderCare Class Action Lawsuit: Investors Reminded of Important Deadline

Purchasers of common stock in KinderCare Learning Companies, Inc. are reminded of the October 14, 2025, lead plaintiff deadline for the class action lawsuit filed against the company. The lawsuit claims that KinderCare's registration statement was false and/or misleading, failing to disclose incidents of child abuse, neglect,

Class action lawsuits

Alto Neuroscience Class Action Lawsuit: Important Deadline Approaching for Investors

Purchasers of common stock in Alto Neuroscience, Inc. who bought the stock as part of its initial public offering (IPO) on February 2, 2024, or between February 2, 2024, and October 22, 2024, may be entitled to compensation due to allegedly false and misleading statements made by the company. The

Class action lawsuits

Altimmune Securities Class Action Lawsuit: Important October 6, 2025 Lead Plaintiff Deadline

The Rosen Law Firm, a global investor rights law firm, reminds investors who purchased securities of Altimmune, Inc. between August 10, 2023, and June 25, 2025, of the October 6, 2025 lead plaintiff deadline. The lawsuit alleges that Altimmune's securities were artificially inflated due to false statements regarding

Class action lawsuits

Securities Class Action Lawsuit Filed Against Snap Inc.

Investors who purchased Snap Inc.'s securities between April 29, 2025, and August 5, 2025, inclusive, have until October 20, 2025, to file lead plaintiff applications in a securities class action lawsuit. The lawsuit alleges that Snap and certain executives failed to disclose material information during this period, violating

Class action lawsuits

Lockheed Martin Securities Class Action Lawsuit: Important Deadlines and Key Information

Purchasers of Lockheed Martin Corporation (NYSE: LMT) securities between January 23, 2024, and July 21, 2025, may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. A class action lawsuit has been filed, and investors are reminded of the September

Class action lawsuits

Securities Class Action Lawsuit Against Neogen Corporation

Neogen Corporation, a leading developer of DNA-based livestock genetic management tools, is at the center of a securities class action lawsuit. The lawsuit, pending in the United States District Court for the Western District of Michigan, alleges that the company's executives failed to disclose material information during a

Class action lawsuits

Pomerantz LLP Announces Class Action Lawsuit Against Replimune Group, Inc.

Pomerantz LLP has announced a class action lawsuit against Replimune Group, Inc. ("Replimune") regarding potential securities fraud and unlawful business practices. The lawsuit concerns the alleged misrepresentation of the efficacy of RP1 (vusolimogene oderparepvec) in combination with nivolumab for the treatment of advanced melanoma. Investors who purchased Replimune

Class action lawsuits

Altimmune Investors Sue Over Alleged Securities Fraud

Altimmune investors who suffered losses after the company's failed trial may be eligible to participate in a class action lawsuit. According to the complaint, Altimmune's management team led investors to believe that the company's Pemvidutide treatment in the Treatment of MASH trial would achieve

Class action lawsuits

Apple Faces Class-Action Lawsuit Over Alleged Copyright Infringement in AI Training Data

The tech giant Apple is facing a class-action lawsuit filed by two authors, Grady Hendrix and Jennifer Roberson, who accuse the company of copyright infringement for allegedly using their books without permission to train its artificial intelligence models. The lawsuit claims that Apple accessed online repositories known as "shadow

Class action lawsuits

Rosen Law Firm Reminds Investors of Lead Plaintiff Deadline in Securities Class Action Lawsuit Against Snap Inc.

Snap investors may be entitled to compensation without paying out-of-pocket fees, with a lead plaintiff deadline set for October 20, 2025. The lawsuit alleges that Snap's optimistic reports about advertising growth and earnings potential fell short of reality, causing investors to suffer damages. Rosen Law Firm, a global

See all